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Of the 42 Areas of Concern (AOCs) identiﬁed
by the International Joint Commission (IJC)
in 1985–1986, six are in New York State.
After release of the 17 studies by Health
Canada reporting disease diagnoses upon
hospital discharge, incidence of birth defects,
and types and incidence of cancer in
Canadian AOCs compared with the rest of
Ontario, Canada, the Science Advisory
Board of the IJC invited the authors to
attempt to obtain comparable data from
New York. 
In New York the Statewide Planning and
Research Cooperative System (SPARCS)
database records all diagnoses upon hospital
discharge for all hospitals covered by Article
28 of New York State law (1). The SPARCS
system, therefore, does not include patients
admitted to federal or Veterans Adminis-
tration hospitals or patients who are New
York residents but who seek medical care out
of state. The SPARCS data set includes all
diagnoses of a patient, whether or not a par-
ticular disease was the cause of hospitaliza-
tion, and also contains personal information
such as age, sex, race, and street address.
Access to this data set is controlled to prevent
misuse of conﬁdential information, but access
to ZIP code of residence without any other
identifying information can be obtained after
a relatively rapid approval process. 
We have used the SPARCS database and
patient ZIP code of residence in an initial
effort to obtain data comparable to the hospi-
tal diagnosis information in the 17 Canadian
reports. The preliminary investigation
reported here focused on combining three of
the six AOCs in New York (Niagara River,
18 Mile Creek, and Buffalo River) on the
basis that these three are contiguous and have
similar contaminants. Detailed descriptions
of these three sites are on the U.S.
Environmental Protection Agency (U.S.
EPA) websites (2–4). A detailed report of
toxic loadings into the Niagara River has also
recently been presented by the U.S. EPA and
the New York State Department of Environ-
mental Conservation (DEC) (5). These bod-
ies of water are affected by local industries.
The Buffalo River discharges into Lake Erie
near the head of the Niagara River, which
connects Lakes Erie and Ontario. The
Niagara River enters Lake Ontario, as does
18 Mile Creek, approximately 18 miles to the
east. These areas include seven federal
National Priority Sites (including Love Canal
and Hooker Chemical sites) plus a number of
state Superfund sites.
In 1988 the U.S. EPA commissioned a
study of toxic pollutant loadings into the
Niagara River and identified 70 sites in the
Buffalo–Niagara Falls area that they
estimated contributed 315 kg/day of toxic
substances into the river (6). Beginning in
1987 the four parties with responsibility, the
U.S. EPA, DEC, Environment Canada, and
the Ontario Ministry of Environment, identi-
ﬁed 18 persistent chemicals as priority toxics.
These included dioxins, polychlorinated
biphenyls (PCBs), four polyaromatic hydro-
carbons, eight persistent pesticides, three met-
als, and tetrachloroethylene. For example, at
the Occidental Chemical Hyde Park site, an
estimated 80,000 tons of chemical wastes
were deposited between 1953 and 1975,
including approximately 0.7–1.6 tons of
dioxin associated with 2,4,5-trichlorophenol
wastes (5). The New York State Department
of Health has issued advisories against eating
almost all fish from both the Buffalo and
Niagara Rivers on the basis of contamination
with PCBs, dioxin, and mirex coming from
these sites (7). 
The potential sources of exposure are
multiple and are not only from the bodies of
water. To evaluate specific health indicators
in the region, we compared all residents of
ZIP codes that are totally or partly within 15
miles of one or more of these bodies of water.
This distance includes all 70 sites identified
near the Buffalo and Niagara Rivers, plus
those near 18 Mile Creek.
We have used three different comparison
populations in order to attempt to control as
best one can for confounding factors other
than environmental contamination. First, we
compared frequency of diagnosis of
endocrine disorders for residents of these
three AOCs with that of the rest of New
York State, except for residents within 15
miles of all six AOCs. However, this compar-
ison includes many people who live near
other contaminated sites. Therefore, we also
compared frequency of diagnosis with resi-
dents of ZIP codes in New York State,
excluding New York City, that do not have
any state or federal Superfund sites, as well as
with those of residents of ZIP codes that
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have a Superfund site but not one where the
listed contaminants of concern do not include
PCBs, dioxins, furans, or persistent pesticides. 
There are clearly some limitations in this
procedure. ZIP codes are not regular or con-
stant in size, and residents of a ZIP code
region may live at some distance from the site
of contamination. Thus, residence within a
ZIP code is only a crude indicator of residen-
tial proximity to a site of environmental cont-
amination. Without personal identiﬁers, or at
least a unique personal number, we cannot
distinguish, for example, three hospitalizations
by the same patient from hospitalizations of
three different individuals. Furthermore, it is
not possible to identify with absolute confi-
dence a control population that is comparable
in all respects other than exposure. A major
limitation is that there are many causes of dis-
ease, and there may be geographic variations
in the risk factors for various diseases that have
nothing to do with environmental contami-
nants. These factors include socioeconomic
status, diet, exercise patterns, genetic factors,
personal habits, access to healthcare, variation
in individual physician diagnostic abilities and
reporting, and numerous other factors that
cannot be evaluated from the use of only these
databases. 
However, there are also major advantages
of the use of these data. Although ZIP codes
provide only an approximate indication of
exposure, by using all hospitalization data one
has large numbers of diagnoses in the denom-
inator (all of New York State except the study
AOCs). Whereas the numerator may be small
if one is dealing with an AOC with a small
population, by pooling residents from urban
AOCs with a relatively large population and
using SPARCS data from a number of years,
we can compare hospitalization diagnoses of a
significant population with those of the rest
of New Yorkers, as well as more restricted
New York comparison populations. Use of
ZIP codes without Superfund sites serves as a
control for exposure, but use of this control
population is limited by the likelihood that
socioeconomic status is greater in such areas.
Therefore, we have used a separate comparison
population living in ZIP codes with Superfund
sites, but ones that do not contain the same
contaminants as in the study area. If patterns
of disease are found consistently over these
three comparisons, then there is at least some
reason for support of the hypothesis that resi-
dential proximity to sites containing persistent
organics increases risk of certain diseases. In
addition, use of the SPARCS data by ZIP code
allows a ﬁrst approach to obtaining informa-
tion comparable to that in the Canadian
reports on the U.S. side of the border.
Methods
The Study Area and Its Population
There are six AOCs in New York State:
Niagara River, Buffalo River, 18 Mile Creek,
Oswego River, the Rochester Embayment and
Genessee River, and the St. Lawrence River
near Massena. Because the initial designation
was based upon these bodies of water, in an
effort to define the community surrounding
the waters, any ZIP code within 15 miles of
the AOC was included in the study area. ZIP
codes were used not only because each repre-
sents a small geographic unit, but also because
they coincide with the New York State
Department of Health data collection process. 
This initial study focused on selected
diagnoses of endocrine diseases of combined
residents of the area near the Niagara River,
Buffalo River, and 18 Mile Creek. These
AOCs are in geographic proximity, and in
general they have the same types of contami-
nants. In addition, this combined area com-
prises a relatively populous region. ZIP codes
within 15 miles of the Buffalo River are
14201, 14202, 14203, 14204, 14210,
14220, 14218, 14219, 14206, 14212,
14227, 14225, 14211, 14209, 14208,
14224, 14127, 14059, 14086, 14083,
14075, 14085, 14052, 14031, 14228,
14150, 14260, 14051, 14221, 14223,
14072, 14014, 14213, 14226, and 14059.
ZIP codes for 18 Mile Creek include 14028,
14008, 14012, 14098, 14105, 14067,
14108, 14094, 14108, 14172, 14174,
14131, 14132, and 14092. ZIP codes for
Niagara River are 14174, 14131, 14172,
14092, 14094, 14132, 14109, 14305,
14301, 14304, 14120, 14068, 14051,
14032, 14031, 14221, 14217, 14223,
14072, 14226, 14228, 14150, 14260,
14207, 14216, 14214, 14215, 14208,
14211, 14201, 14203, 14222, 14202,
14213, 14209, 14212, 14206, 14210,
14220, 14225, 14227, 14224, 14026,
14043, 14059, 14086, and 14303. Figure 1
shows the locations of the study area.
According to the 2000 U.S. census, the
population living in ZIP codes within 15
miles of the Niagara River, Buffalo River, and
18 Mile Creek was 1,102,158. The popula-
tion of New York State in 2000 was
16,224,726. Hence, the study area popula-
tion represents 6.7% of the state population.
However, we also excluded from considera-
tion those persons residing within 15 miles of
the other three AOCs in this comparison. 
Two other comparison populations were
identiﬁed. New York DEC has identiﬁed 865
state Superfund sites and lists location and
major contaminants for each site. The state
listing includes all federal National Priority
Sites. We reviewed this list, identiﬁed all ZIP
codes containing a state or federal Superfund
site, then further identified those where
PCBs, dioxins, furans, or persistent pesticides
are listed as major contaminants. In the case
of Superfund sites that are bodies of water,
such as the Hudson River, we included every
ZIP code that abuts the river in the region of
contamination in this category. In these
analyses we excluded New York City, which
differs signiﬁcantly from the rest of New York
in many ways. We identified all ZIP codes
that are not in New York City and that do
not contain or abut any Superfund site.
There are 1,258 such ZIP codes, with a pop-
ulation of 4,641,170 persons. These we call
“clean” ZIP codes. Because it is likely that per
capita income is higher in clean areas than in
those containing Superfund sites, we also
identiﬁed all ZIP codes that contain or abut a
Figure 1. Map of the study area in western New York State, designed to include all ZIP codes within 15 miles of the
Buffalo River, Niagara River, and 18 Mile Creek.
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Superfund site but that do not list PCBs,
dioxins, furans, or persistent pesticides as
major contaminants. Most of these have
metals or volatile organics as the major conta-
minants. Although these contaminants may
also cause health effects, they would be
expected for the most part not to be identical
to those induced by persistent organics.
Furthermore, the per capita income in these
areas is likely to be more similar to that in
areas with Superfund sites containing the per-
sistent organics. There were 1,499 such ZIP
codes, with a total population of 7,772,250.
Data Used
The disease occurrence data were obtained
from the SPARCS inpatient database for
1993–1998. This data set contains the claims
and discharge data for all inpatient stays in
Article 28 facilities (hospitals and clinics) in
New York State, with approximately 2.5 mil-
lion records per year. The data include sex,
age, ZIP code of residence of the patient, and
the diagnosis reported by the hospital or
clinic for each patient, based on the
International Classification of Disease, Ninth
Revision (ICD-9) codes (8). All diagnoses are
reported for each hospitalized patient,
whether or not any particular disease was the
cause of hospitalization. The data were not
adjusted for either multiple visits or for trans-
fers between and within hospitals, and do not
include visits to doctor’s ofﬁces or outpatient
departments or clinics. To increase the statis-
tical power of the analyses and the conﬁdence
in the results obtained, data from 1993 to
1998 were considered together, giving more
than 8 million hospitalizations.
The population data were extracted from
Summary Tape File 3B of the U.S. 2000
Census of population and housing. The data
contain 100% counts of population (by sex
and by age) at the ZIP code level. The 2000
Census was used because there is no public-
use data available at the ZIP code level for
noncensus years 1993–1998. By using these
population data we assume that the popula-
tion structures kept stable from 1993 to 2000
in the study area and the comparison area.
Data Analysis
To compare disease frequency in the two pop-
ulations, we determined diagnosis of a particu-
lar disease as the annual number of diagnoses
per 100,000 population. As females and males
have different patterns of morbidity, we used a
sex-speciﬁc approach to analyze the data. Rates
were also adjusted to reﬂect a standard age dis-
tribution. This procedure, termed “direct age
standardization,” minimizes possible effects
due to differences in age composition when
comparing data from different populations (9). 
The sex-speciﬁc U.S. population in 2000
was the standard population used in the
direct age standardization process. The direct
age-standardized morbidity rates (ASMR)
were calculated by the formula 
ASMRi = wi(di/ni) [1.1] 
where wi is the fraction of the standard popu-
lation (sex-speciﬁc) falling within age group i,
di is the number of hospitalizations for the
period of study in age group i, and ni is the
person-years at risk for the period under
study in age group i. To calculate the annual
standardized rate, we divided the number of
years of data analyzed by 6. Standardization
was done for populations divided into 19 age
groups consisting of one group of infants less
than 1 year of age, a group of preschoolers
1–4 years old, 16 consecutive groups span-
ning 5-year age intervals, and a ﬁnal group of
elderly adults over 85 years of age. In some
analyses, wider age groups (0–24 years,
25–44 years, 45–74 years, and ≥75 years of
age) were used to be comparable to the
Canadian analyses. Because a certain number
of positive relationships should be found by
chance, we focused on consistency of the dif-
ferences between the ASMRs of the two areas
over the age groups, comparing males and
females, and on consistency using the three
comparison populations. A summarized age-
standardized morbidity rate (SASMR) was
then calculated by the formula
SASMRj = Σwi(di/ni) [1.2] 
where j is an age category and i is the age
group within this age category. The Z-test for
the difference between the SASMRs for the
study-area population and the comparison
area population were then applied to deter-
mine the statistical significance of the com-
parison. The null hypothesis is that there is
no difference between the two populations,
and the corresponding research hypothesis is
that there is some difference. Statistical study
has shown that the distribution of an SASMR
is skewed (10). To improve the normal
approximation, log-transformed SASMRs
were used, and standard errors were con-
structed for the transformed SASMRs. The
formula of Z-test (11) is
[1.3]
where SASMRa is the SASMR for the study-
area population for the specified age cate-
gory; SASMRb is the SASMR for the
comparison-area population for the speciﬁed
age category, and
[1.4]
In formula [1.4], Ni is the person-years
for the period under study in age group i of
the standard population within the speciﬁed
age category; ni is the person-years at risk for
the period under study in age group i of the
specific population within the specified age
category; and pi is the age-speciﬁc morbidity
rate for the age group i within the specified
age category. All rates are expressed as
annual rates. The p-value derived from this
test is the probability that the actual differ-
ence in SASMRs between the study area and
comparison area populations is greater than
or equal to the calculated difference of Z.
The only results reported are at the level of
signiﬁcance p < 0.01. 
Selected Health Outcomes
We considered only selected endocrine health
outcomes for this preliminary study. These
were selected on the basis of a reasonable
hypothesis relating disease to exposure to envi-
ronmental contaminants present in the AOCs.
The selected health outcomes, with the corre-
sponding ICD-9 codes, are as follows:
• Disorders of thyroid gland (240–246)
• Ovarian dysfunction (255)
• Testicular dysfunction (257)
• Diseases of female genital tract (617–629)
–Endometriosis (617)
–Infertility female (628)
Results 
Figure 2 shows ASMR of disorders of the
thyroid gland (ICD-9 240–246) for females,
whereas Figure 3 shows similar results for
males who reside in ZIP codes within 15
miles of the Niagara River, Buffalo River, or
18 Mile Creek (second bar from left), com-
pared with the rest of New York State except
for the six AOCs (left bar), the clean areas
(second bar from right), and ZIP codes with
other Superfund sites (right bar). There is a
consistent elevation in incidence of thyroid
disorders in women at all ages >24 years in
the AOCs when compared with those in all
three comparison populations, whereas no
such relationship is obvious for men. As
expected, the ASMR for thyroid disease for
females is much greater than that for males.
Figure 4 shows results for disorders of the
female genital tract (ICD-9 codes 617–629).
As for thyroid disease, there is a significant
and consistent elevation in the diagnosis of
female genital tract disorders in the three
AOCs when compared with those in all three
comparison populations at ages >25 years.
We examined two speciﬁc diseases in women.
Infertility in females was not signiﬁcantly dif-
ferent from the rest of the females of New
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York State. Incidence of endometriosis was
elevated in the study area in women for all
ages >24 years (Figure 5). There was also no
signiﬁcant difference in diagnosis of testicular
dysfunction between comparison groups. 
Tables 1–3 show the Z-test sign and
significance, if any, at the p < 0.01 level for
SASMR for all observations for these ICD-9
codes based on ages 0–24, 25–44, 45–74,
and ≥75 years. Table 1 shows the results of
comparison with residents of all of New York
State except for the six AOCs. Table 2 shows
comparison with residents of ZIP codes that
do not contain any Superfund site, and
Table 3 shows comparison with residents of
all ZIP codes that contain a Superfund site
that does not list persistent organics among
the contaminants of concern. Note that there
is consistency across the three comparison
populations for all significant differences
with the exception of endometriosis in the
45- to 75-year-old age group. 
Discussion
Several endocrine diseases appear to be more
common among residents who live in ZIP
codes near the three AOCs in New York
State. Although there are a number of possi-
ble explanations for these differences, the dis-
eases that are elevated are among those also
elevated in some of the Canadian AOCs.
These consistencies lend support for the
hypothesis that exposure to environmental
contaminants present in the vicinity of the
Buffalo and Niagara Rivers and 18 Mile
Creek may contribute to the elevated inci-
dence of these diseases. However, we cannot
rule out the possibility that the similarities
result from a common set of confounders in
western New York State and sites in Ontario
near the Great Lakes.
The hypothesis behind these studies is
that residential proximity to a hazardous
waste site is a risk factor for elevated exposure
to toxic substances and subsequent disease.
There is only limited evidence to support this
hypothesis. Yaffe and Reeder (12) did not
detect elevated PCB levels in children living
in an area of PCB contamination in a
Toronto community compared to those in a
control area. However, Stehr-Green et al.
(13) reported that people living near waste
sites had a higher average serum PCB level,
and a greater percentage had PCB levels ele-
vated with respect to the average U.S. level.
Geschwind et al. (14) and Dolk et al. (15)
have both reported elevated incidence of birth
defects in individuals living near hazardous
waste sites, but other studies have not seen
this relationship (16). 
There are a number of exposure pathways
that might contribute to body burden,
including consumption of local ﬁsh or other
wildlife, inhalation of volatile contaminants,
Figure 2. ASMR of thyroid gland disorders in females as a function of age in the study area (second bar from left)
compared with the rest of New York State minus the population of all six AOCs (left bar), all clean ZIP codes outside
of New York City (second bar from right), and all ZIP codes outside of New York City that have a Superfund site but
do not have persistent organic pollutants as a major contaminant (right bar). 
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Figure 4. ASMR for diseases of female genital tract as a function of age in the study area (second bar from left)
compared with the rest of New York State minus the population of all six AOCs (left bar), all clean ZIP codes exclud-
ing New York City (second bar from right), and all ZIP codes outside of New York City containing a Superfund site that
does not have persistent organic pollutants. 
Figure 3. ASMR of thyroid gland disorders in males as a function of age in the study area (second bar from left)
compared with the rest of New York State minus the population of all six AOCs (left bar), all clean ZIP codes exclud-
ing New York City (second bar from right), and all ZIP codes outside of New York City containing a Superfund site that
does not have persistent organic pollutants. Note that the ASMR scales are different for women (Figure 2) and men. 
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and dermal absorption from swimming or
wading. It is also possible that dust from con-
taminated sediments is ingested through a
variety of routes by those living near these
contaminated sites. Griffith et al. (17) have
shown an association between residence near
hazardous waste [National Priority List (18)]
sites and incidence of various cancers.
Vrijheid (19) recently reviewed residence near
hazardous waste sites and various disease and
concluded that various adverse health effects
correlate with such residential proximity,
although biases and confounders cannot be
excluded as explanations for at least some of
the reported relationships.
Not all Canadian AOCs show a similar
pattern of disease. In fact, they appear to
break down into at least two different groups
on the basis of whether there are elevations
in disease in general, as well as in speciﬁc dis-
eases. For example, 14 of the 17 AOCs show
elevated rates of hospitalization for both men
and women, significant at the 99% confi-
dence level. The exceptions were Wheatley,
Metro Toronto, and Hamilton Harbor.
These three AOCs, compared to the rest of
Ontario, report a lower incidence of diagno-
sis of several of the diseases that one can
hypothesize being related to endocrine dis-
ruption from the contaminants of concern.
Other Canadian AOCs showed elevations for
some, but by no means all, of the diseases
under consideration. For example, hospital-
izations for disease of the female genital tract
were elevated in 12 AOCs, all at the 95%
confidence level. The exceptions were
Wheatley and Port Hope, which were not
different from the rest of Ontario, and
Hamilton Harbor, Metro Toronto, and Bay
of Quite, which were statistically signiﬁcantly
less than the rest of Ontario. 
Thyroid Disease
One of the most striking elevations in our
study was that for thyroid disease in women.
These ICD-9 codes include goiter, hyper- and
hypothyroidism, thyroiditis, and other thy-
roid disorders. There was a consistent eleva-
tion in hospital diagnoses for residents of the
study area compared with those of all three
comparison populations, and both the inci-
dence and the difference increased with age.
This is consistent with what was found in
some of the Canadian studies, where thyroid
disease was elevated in women but not men
from the Detroit River, St. Clair River, St.
Mary’s River, Collingwood, Jackfish, and
Metro Toronto AOCs. 
There is clear evidence from animal
studies to support the hypothesis that PCBs
and dioxin/furans interfere with thyroid
function, probably secondary to the fact that
the structures of these molecules are some-
what similar to that of thyroid hormone.
Experimental administration of PCBs results
in altered thyroid structure and function.
Chronic exposure to Aroclor mixtures results
in an enlargement of the colloid droplets
within the follicular cells and follicular cell
hyperplasia (20,21). Aroclors at doses as low
as 0.9 mg/kg/day for 35 days produce
changes in the thyroid gland, which implicate
direct damage (22). However, different PCB
congeners have very different potencies (23),
and as both ortho-substituted and coplanar
congeners alter thyroxine (T4) levels, it is
unlikely that Ah-receptor activation is
involved. Depending upon the dose, the
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Table 1. SASMR for study area compared with the rest of New York State.
Age categories (years)
Causes of hospitalization 0–24 25–44 45–74 ≥75
Disorders of thyroid gland (female) NS + + +
Disorders of thyroid gland (male) NS NS NS NS
Other disorders of female genital tract NS + + +
Endometriosis NS + + NS
Infertility NS NS NS NS
Ovarian dysfunction NS NS NS NS
Testicular dysfunction NS NS NS NS
Abbreviations: +, sign of the Z-value with p < 0.01; NS, SASMR not signiﬁcantly different from 1.
Table 2. SASMR for study area compared with all clean areas.
Age categories (years)
Causes of hospitalization 0–24 25–44 45–74 ≥75
Disorders of thyroid gland (female) NS + + +
Disorders of thyroid gland (male) NS NS NS NS
Other disorders of female genital tract NS + + +
Endometriosis NS + NS NS
Infertility NS + NS NS
Ovarian dysfunction NS NS NS NS
Testicular dysfunction NS NS NS NS
Abbreviations: +, sign of the Z-value with p < 0.01; NS, SASMR not signiﬁcantly different from 1.
Table 3. SASMR for study area compared with all areas with other waste sites.
Age categories (years)
Causes of hospitalization 0–24 25–44 45–74 ≥75
Disorders of thyroid gland (female) NS + + +
Disorders of thyroid gland (male) NS NS NS NS
Other disorders of female genital tract NS + + +
Endometriosis NS + NS NS
Infertility NS NS NS NS
Ovarian dysfunction NS NS NS NS
Testicular dysfunction NS NS NS NS
Abbreviations: +, sign of the Z-value with p < 0.01; NS, SASMR not signiﬁcantly different from 1.
Figure 5. ASMR for endometriosis, a subdivision of diseases of female genital tract (Figure 4), for residents of the
study area (second bar from left) compared with those of all of New York minus the six AOCs (left bar), all clean ZIP
codes (second bar from right), and residents of all ZIP codes that have Superfund sites not containing the contami-
nants of concern.
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time of exposure, and the congeners, PCBs
either decrease or mimic thyroid function
(24). Both Aroclor 1254 (25) and some single
congeners (26,27) have been reported upon
chronic treatment to result in a decrease in
serum T4. However, one study has reported
an increase in both triiodothyronine (T3) and
T4 with either ingestion and inhalation expo-
sure to Aroclor 1242 (28), and Desaulniers et
al. (26) found that whereas chronic exposure
to PCB 126 reduced both T3 and T4 in a
dose-dependent fashion, PCB 153 resulted in
increased T4. Thus, different PCB congeners
may have different effects. The recent paper
by Zoeller et al. (29) provides particularly
clear evidence that a PCB mixture, Aroclor
1254, has diverse effects on developing ani-
mals. They demonstrated that developmental
exposure resulted not only in reduced T4 but
also in an increased expression of genes that
are stimulated by thyroid hormone.
PCBs probably interfere with thyroid
function at multiple sites. PCBs bind to
transport proteins and in so doing displace
thyroid hormones (30). They activate glu-
curonidating enzymes, which further
increases excretion (31). In addition they may
induce direct effects on the thyroid through
the inhibition of proteolysis of thyroglobulin
(32). Even less is known about the actions of
the various metabolites of PCBs, although it
is clear that some of these also have the ability
to disrupt thyroid function. Methylsulfonyl
metabolites of tetra- and pentachlorinated
congeners reduce T3 and T4 and cause an
increase in thyroid-stimulating hormone
(TSH) levels (33). Hydroxylated PCB
metabolites inhibit deiodinase type 1 and T2-
sulfotransferase activity (30), and bind to
transthyretin, and in so doing displace T4
(34). Cheek et al. (35) found that it was only
the hydroxylated PCBs, not the parent
compounds, that bound to transthyretin and
thyroid-binding globulin and report that they
had the same affinity for transthyretin as
thyroid hormone. They may also activate uri-
dine diphosphate-glucuronyltransferase,
which then increases the biliary excretion of
T4-glucuronide (31,36). In a recent review,
Brucker-Davis (37) concluded that except in
the fetus the major mode of action of copla-
nar congeners is through increased glu-
curonidation, whereas the ortho-substituted
congeners, and particularly their oxidative
metabolites, act through multiple other path-
ways, including interference with transport
proteins, direct action on the thyroid gland,
and changes in the kinetics of thyroid
hormone metabolism. 
We previously reported a striking excess
of hypothyroidism in older women from a
different AOC, the Mohawk population liv-
ing at Akwesasne on the St. Lawrence River
at the juncture of Ontario, Canada, and New
York (38), and we are currently relating
serum PCB concentration in this population
to disease incidence. In Mohawk adolescents
our colleagues demonstrated a significant
direct relationship between serum PCB level
and the levels of TSH and an inverse rela-
tionship with serum-free and total T4 (39).
This relationship is particularly striking
because the PCB levels are relatively low,
having a geometric mean of 1.82 ppb and a
maximum of 4.75 ppb in these children.
These levels are not different from those
found in most people in developed countries.
Nevertheless, this observation of a relationship
to serum PCB levels suggests that these back-
ground levels of PCBs exert signiﬁcant effects
on thyroid hormone levels. Emmett et al. (40)
demonstrated decreased serum T4 levels in
workers occupationally exposed to PCBs. 
The results of the study by Schell et al.
(39) are important in considering our results
using the SPARCS data in that the Schell
study included direct measurement of serum
PCB levels. Although the adolescents in their
study were not diagnosed with thyroid disease,
the direct relationship between PCB levels and
alterations in thyroid hormones adds support
to the hypothesis that PCB levels may con-
tribute to thyroid disease. In addition, these
effects are occurring at PCB concentrations
that could conceivably be influenced by
residence in proximity to an AOC. 
Sex Steroids
We investigated several diagnoses related to
sex steroid function. We did not detect any
difference in the study area for diagnoses of
ovarian or testicular dysfunction. However,
there was a striking elevation in the incidence
of other disorders of the female genital tract,
some of which were due to an elevated inci-
dence of endometriosis. The Canadian
reports also documented an elevated inci-
dence of female genital disease in AOCs (41).
Many of the contaminants in the AOCs
have the potential to alter incidence of
endocrine disease. DDT and its metabolites
are estrogenic (42). Several pesticides alter
estradiol metabolism (43) and increase birth
defect incidence (44). Dioxin exposure
results in an elevation in incidence of
endometriosis in monkeys (45), and some
human studies are consistent with this con-
clusion (46). However, a more recent publi-
cation from the same authors (47) reports
that the prevalence of endometriosis in
dioxin-treated animals correlated with the
concentration of one coplanar PCB con-
gener, 3,4,3´,4´-tetrachlorobiphenyl (PCB
77), and not that of dioxin, although the
source of PCB exposure was not known. It is
not clear whether it is the dioxin exposure
rather than serum levels, or the levels of PCB
77 that is related in induction of the disease.
Dioxin functions as an anti-estrogen, primarily
secondary to the fact that dioxin and other
dioxinlike substances (furans and coplanar
PCBs) induce liver P450 enzymes that
degrade estrogen (48) and/or cause a reduc-
tion in the numbers of estrogen receptors
(49). However, other PCBs, and particularly
the hydroxy metabolites of some PCB con-
geners, are estrogenic, including PCB 77
(50,51). Although the factors that promote
endometriosis are not well understood, both
immune and endocrine dysregulation are
believed to be involved (52).
Our observations are noteworthy on
several counts. We did not observe differ-
ences in fertility in women nor an elevated
incidence of dysfunction of ovaries or testes.
However, it is not clear that the SPARCS
database is the best place for obtaining accu-
rate diagnoses for these diseases. Most
patients with fertility problems will obtain
medical treatment on an outpatient basis;
furthermore, infertility is not likely to be
identified on records of hospitalization for
other causes. The striking elevation of
endometriosis is, however, consistent with
exposure to dioxin and/or PCB 77. The
study region near the Buffalo River, Niagara
River, and 18 Mile Creek is known to have
high dioxin levels at some sites. For example,
a leachate from Love Canal contained 3 ppm
dioxin, and that component accounted for
all the adverse effects of leachate given to rats
(53). The mechanism by which dioxin
and/or PCBs induce endometriosis in mon-
keys is not known, but our observations,
together with those of Pauwels et al. (46), are
consistent with the hypothesis that a similar
relationship exists in women. The diagnosis
of endometriosis was greater in the AOCs
than in the control, even at older ages,
although it was much less than in the 30- to
50-year age range. It is interesting that post-
menopausal endometriosis has been associ-
ated with hormone replacement therapy
(54,55). Conceivably, an endocrine-disrup-
tive xenobiotic could induce similar disease. 
Conclusions
It is entirely possible that the results reported
here are unrelated to the environmental con-
tamination of the Buffalo and Niagara Rivers
and 18 Mile Creek. However, it is not obvi-
ous what other factors would result in these
specific endocrine diseases being elevated
compared with those in each of the three
comparison groups. Certainly there are
numerous risk factors for each of these dis-
eases, and exposure to PCBs, dioxin/furans,
and persistent pesticides would probably not
be listed as the major risk factors by most
knowledgeable professionals. Nonetheless,
our observations, in conjunction with the
Canadian studies detailed in this SupplementEndocrine disease in Areas of Concern
(41,56), provide support for the hypothesis
that environmental contaminants contribute
to the incidence of these diseases, and that
simply living near a contaminated site results
in an increase in exposure, which is reﬂected
in elevated disease diagnosis among those resi-
dents. This hypothesis must be further tested
at different sites and with direct measurement
of biomarkers of exposure.
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